Augmenting the Quality and Duration of the Immune Response with a Novel TLR2 Agonist-Aluminum Combination Adjuvant

NIH RePORTER · NIH · N43 · $300,000 · view on reporter.nih.gov ↗

Abstract

The goal of this project is to optimize a novel adjuvant formulation composed of alum and a TLR2 agonist to improve performance of a DTaP subunit vaccine.

Key facts

NIH application ID: 10499193
Project number: 75N93021C00057-0-9999-1
Recipient: TEICHOS LABORATORIES, LLC
Principal Investigator: LARRY BLASZCZAK
Activity code: N43
Funding institute: NIH
Fiscal year: 2021
Award amount: $300,000
Award type: —
Project period: 2021-09-30 → 2022-09-29